Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
HERON THERAPEUTICS, INC. /DE/
| Metric | HERON THERAPEUTICS, INC. /DE/ HRTXHealthcare |
|---|---|
| Quality Score | 50 / 100 |
| Revenue (latest) | $155M |
| Net income (latest) | −$20M |
| Operating margin | −1.6% |
| Net margin | −13.0% |
| Return on equity | −140.9% |
| Return on assets | −7.9% |
| Return on capital (ROCE) | −1.6% |
| Debt / equity | 16.85× |
| Revenue growth (YoY) | 7.4% |
| Altman Z″ (distress) | -21.08 |
| Accruals / assets | 2.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.